
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5726-5731
Open Access | Times Cited: 17
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5726-5731
Open Access | Times Cited: 17
Showing 17 citing articles:
Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan
Cheng-Yi Lee, Hung-Wei Kuo, Yulun Liu, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 7
Cheng-Yi Lee, Hung-Wei Kuo, Yulun Liu, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 7
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
Clinical Immunology (2023) Vol. 255, pp. 109762-109762
Open Access | Times Cited: 19
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
Clinical Immunology (2023) Vol. 255, pp. 109762-109762
Open Access | Times Cited: 19
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
Rossella Cianci, Laura Franza, Giulia Pignataro, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 373-373
Open Access | Times Cited: 5
Rossella Cianci, Laura Franza, Giulia Pignataro, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 373-373
Open Access | Times Cited: 5
The humoral response to COVID-19 vaccinations can predict the booster effect on health care workers—toward personalized vaccinations?
Ophir Freund, Alma Harish, Anna Breslavsky, et al.
Journal of Public Health (2023) Vol. 46, Iss. 1, pp. e78-e83
Closed Access | Times Cited: 4
Ophir Freund, Alma Harish, Anna Breslavsky, et al.
Journal of Public Health (2023) Vol. 46, Iss. 1, pp. e78-e83
Closed Access | Times Cited: 4
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Serum concentration of antigen-specific IgG can substantially bias interpretation of antibody-dependent phagocytosis assay readout
Russell St. Germain, Emily L. Bossard, Lawrence Corey, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107527-107527
Open Access | Times Cited: 2
Russell St. Germain, Emily L. Bossard, Lawrence Corey, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107527-107527
Open Access | Times Cited: 2
The Comparative Superiority of SARS-CoV-2 Antibody Response in Different Immunization Scenarios
Ourania S. Kotsiou, Nikolaos D. Karakousis, Dimitrios Papagiannis, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 4
Ourania S. Kotsiou, Nikolaos D. Karakousis, Dimitrios Papagiannis, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 4
Robust immune response to COVID-19 vaccination in the island population of Greenland
Mie Møller, Lennart Friis‐Hansen, Nikolai Kirkby, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access
Mie Møller, Lennart Friis‐Hansen, Nikolai Kirkby, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
Vilija Gurkšnienė, Tadas Alčauskas, Fausta Majauskaitė, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1419-1419
Open Access
Vilija Gurkšnienė, Tadas Alčauskas, Fausta Majauskaitė, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1419-1419
Open Access
Response Rate to the 3rd and 4th Doses of BNT162b2 Vaccine in Cancer Patients Administered with Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
SARS-CoV-2 antibody response to third dose vaccination in a healthy cohort
Patel Simmi, Wheeler Sarah E, Anderson Adam, et al.
Insights in Clinical and Cellular Immunology (2022) Vol. 6, Iss. 1, pp. 008-013
Open Access | Times Cited: 1
Patel Simmi, Wheeler Sarah E, Anderson Adam, et al.
Insights in Clinical and Cellular Immunology (2022) Vol. 6, Iss. 1, pp. 008-013
Open Access | Times Cited: 1
Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Authorea (Authorea) (2023)
Open Access
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Authorea (Authorea) (2023)
Open Access
Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Incidence of unknown COVID-19 infection in a cohort of emergency physicians and advance practice providers
Aaron Barksdale, Macy G. Wood, Chad E. Branecki, et al.
The American Journal of Emergency Medicine (2022) Vol. 64, pp. 155-160
Open Access
Aaron Barksdale, Macy G. Wood, Chad E. Branecki, et al.
The American Journal of Emergency Medicine (2022) Vol. 64, pp. 155-160
Open Access